Compare Globalstar (GSAT) vs Iovance Biotherapeutics Inc. Common Stock (IOVA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Globalstar vs Iovance Biotherapeutics Inc. Common Stock — how do they compare? Globalstar trades at $83.82 (market cap $10.78B), while Iovance Biotherapeutics Inc. Common Stock trades at $14.62 (market cap $6.04B). The key difference: Globalstar is the larger of the two by market cap, and Globalstar is more actively traded (723,953 versus 14,805,993). Which is the better fit depends on your goals — on Pluang, investors hold Globalstar for 21 Days and Iovance Biotherapeutics Inc. Common Stock for 0 Days on average.
| GSAT | IOVA | |
|---|---|---|
Market Cap | $10.78B | $6.04B |
Volume | 723,953 | 14,805,993 |
Sector | Media | Health |
52-Week High | $84.43 | $14.82 |
52-Week Low | $41.54 | $1.81 |
Typical Hold Time | 21 Days | 0 Days |
Enterprise Value | $10.79B | $5.97B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Globalstar
Globalstar provides satellite and terrestrial connectivity services, including voice, data, asset tracking, and private wireless solutions. It operates a low-Earth-orbit satellite network and holds licensed mid-band spectrum.
Read more on GSAT →About Iovance Biotherapeutics Inc. Common Stock
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →
